Report synthesizes curcumin's NF-kB inhibition and evaluates its clinical relevance across diseases, indicating potential benefits for treatment strategies.
This report synthesises the molecular pharmacology of curcumin's NF-kB inhibition cascade, evaluates bioavailability enhancement strategies across 8 delivery technologies, and reviews highest-quality clinical evidence across four priority disease areas including osteoarthritis, IBD, type 2 diabetes, and neurodegeneration. Regulatory considerations for nutraceutical dossier preparation are addressed. Author ORCID: 0009-0008-0463-3573
No takes yet. Share an insight, caveat, or question.
KHALID MOHAMMED A.S. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: